Sabra Health Care REIT Revises FY24 Normalized AFFO From $1.41-$1.44 To $1.43-$1.44; Normalized FFO From $1.36-$1.39 To $1.39-$1.40
Sabra Health Care REIT Revises FY24 Normalized AFFO From $1.41-$1.44 To $1.43-$1.44; Normalized FFO From $1.36-$1.39 To $1.39-$1.40
Previous Guidance2024 GUIDANCE
2024年指導
Sabra is updating its 2024 earnings guidance ranges as follows (attributable to common stockholders, per diluted common share):
Sabra正在更新其2024年度盈利指導範圍，如下（歸屬於普通股股東，每股攤薄普通股）：
Updated Guidance
更新指引
- Net Income: $0.48 - $0.49
- FFO: $1.35 - $1.36
- Normalized FFO: $1.39 - $1.40
- AFFO: $1.41 - $1.42
- Normalized AFFO: $1.43 - $1.44
- 淨利潤: $0.48 - $0.49
- FFO: $1.35 - $1.36
- Normalized FFO: $1.39 - $1.40
- AFFO: $1.41 - $1.42
- Normalized AFFO: $1.43 - $1.44
Previous Guidance
先前的指引
- Net Income: $0.48 - $0.51
- FFO: $1.33 - $1.36
- Normalized FFO: $1.36 - $1.39
- AFFO: $1.39 - $1.42
- Normalized AFFO: $1.41 - $1.44
Guidance ranges assume year-over-year same store Cash NOI growth in the mid-to-high teens for the managed senior housing portfolio. Guidance also incorporates all announced investment and disposition activity, as well as announced activity under the at-the-market equity offering program. Guidance does not assume additional investment, disposition or capital transactions beyond those already disclosed.
The foregoing guidance ranges reflect management's view of current and future market conditions. There can be no assurance that the Company's actual results will not differ materially from the estimates set forth above. Except as otherwise required by law, the Company assumes no, and hereby disclaims any, obligation to update any of the foregoing guidance ranges as a result of new information or new or future developments.
- 淨利潤: $0.48 - $0.51
- FFO: $1.33 - $1.36
- 標準化FFO: $1.36 - $1.39
- AFFO: $1.39 - $1.42
- 標準化AFFO: $1.41 - $1.44
指導範圍假設託管的高級住房投資組合的年度同店現金淨營收增長在中至高十幾個百分點。指導還包括所有已宣佈的投資和處置活動，以及根據市場價格進行的隨時以市場爲基礎的股權發行計劃，指導不包括除已披露的那些之外的額外投資、處置或資本交易。
上述指導範圍反映了管理層對當前和未來市場條件的看法。公司不保證實際結果與上述估計不會有重大差異。除非法律另有規定，否則公司不承擔任何義務，並在此否認根據新信息或新的或未來發展更新上述任何指導範圍的義務。
Commenting on the third quarter's results, Rick Matros, CEO and Chair, said, "It feels good to be providing essentially the same update as the last several quarters. Skilled nursing and managed senior housing continue to see higher occupancy and margins. EBITDARM coverage for our skilled nursing portfolio has surpassed 2019 levels, while our triple net senior housing portfolio is approaching that milestone. Among our key triple-net relationships, the only tenant that saw a sequential coverage decline was Avamere, but that was specifically due to the percentage rent we have been collecting as performance improves. Avamere's coverage remains healthy, and the lease restructure has worked out exactly as anticipated.
針對第三季度的業績，首席執行官兼董事長Rick Matros表示：“能夠提供與過去幾個季度基本相同的更新感覺很好。 技術護理和管理的高級住房繼續看到更高的佔用率和利潤率。 我們的技術護理組合的EBITDAR覆蓋率已超過2019年的水平，而我們的三重淨租賃高級住房組合正在接近這一里程碑。 在我們的關鍵三網關係中，唯一看到順序覆蓋率下降的租戶是Avamere，但這主要是由於我們收回的百分比租金隨着績效的提高而改善。 Avamere的覆蓋率仍然健康，而租約重構的效果正如預期的那樣。
Leverage continues to tick down. Investments for the quarter and subsequent to quarter end totaled roughly $100 million, including those previously announced. Our investment pipeline has seen increased activity, and we are currently reviewing more potential investments than we have seen all year.
槓桿繼續下降。 本季度和季度結束後的投資總額約爲10000萬美元，包括之前宣佈的投資。 我們的投資管道活動增加，目前正在審查的潛在投資比我們整年看到的都多。
Additionally, we have increased the midpoint of our guidance, which implies year-over-year earnings growth of more than 6% for the full year."
此外，我們已經提高了指導範圍的中點，這意味着整年的盈利增長將超過6%。
譯文內容由第三人軟體翻譯。